The first Russian tetravalent vaccine for prevention of influenza meeting all the recommendations of the World Health Organization in terms of its formula and quantity of hemagglutinin in each influenza strain
active ingredients – influenza virus antigens – are obtained from the purified influenza A and B viruses grown separately in developing chicken embryos
one dose of the vaccine contains a total of 60 µg of antigens
without preservatives, stabilizers and adjuvants
meets the immunogenicity criteria for inactivated influenza vaccines, accepted in the European Union and the Russian Federation
the fill-finish production in Russia complies with the GMP standards
The vaccine is indicated for active annual preventive seasonal influenza immunization of people aged 18 to 60.
The vaccine is especially indicated for:
1. People at high risk of contracting influenza and occurrence of its complications:
people frequently suffering from acute respiratory viral infections;
people suffering from chronic somatic diseases, including diseases and congenital abnormalities of the cardiovascular, respiratory and central nervous systems, chronic kidney diseases, metabolic diseases, diabetes, chronic anemia, allergic diseases (except for chicken protein allergy), congenital or secondary immunodeficiency, including infected with human immunodeficiency virus.
People at high risk of contracting influenza from others due to their professional activity: workers of healthcare and educational facilities, transportation, municipal and social sectors, police, military personnel, etc.
